Jen Doherty

Jen Doherty currently serves as Director II for Solid Tumor Commercial Analytics at AbbVie since May 2025, and as Director II for Hematology Commercial Insights and Analytics at Pharmacyclics, an AbbVie Company, since April 2022. Prior to these roles, Jen Doherty held various positions at AbbVie, including Director II for Hematology Commercial Analytics, where significant contributions included pioneering patient opportunity suggestions using machine learning models. Other notable achievements include creating a novel marketing mix model to assess promotional response in oncology and evaluating nearly $200 million in television investment through innovative data sources and models. Jen Doherty holds an M.B.A. in Finance from Indiana University Indianapolis and a B.S. in Biology from Indiana University Bloomington.